This is test text to fill space.
Introduction
COVID-19
The viral SARS-CoV-2 membrane is covered in spike proteins. These proteins are what enable the virus to enter our cells via interaction with membrane surface proteins called "angiotensin-converting enzyme 2" (ACE-2) receptors. SARS-CoV-2 spike proteins to induce phagocytosis of the receptor-viral body complex.
Function
The minibinder associates with the SARS-CoV-2 spike protein binding domain for ACE-2 before it reaches a host cell.
Stability
Placeholder Image to be Replaced
Structure sourced from original source paper Longxing et al.
[1]
and also
Binding Site